Skip to main content
3775 search results for:

Acromegaly 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. Open Access 01-12-2024 | Acromegaly | OriginalPaper

    Pregnancy and acromegaly: clinical outcomes of retrospectively analysed data from the German acromegaly registry

    The care of pregnant women with acromegaly is challenging, in part due to existing clinical data being limited and not entirely consistent with regard to potential risks for mother and child. Our registry belongs to the largest data collections …

  2. Open Access 26-04-2024 | Acromegaly | Online First

    Uterine fibroids in women diagnosed with acromegaly: a systematic review

    The review discusses the relationship between acromegaly and uterine fibroids. It highlights variations in research methodologies and inconsistent findings, emphasizing the complex nature of fibroid development and the role of the somatotropic …

  3. Open Access 06-05-2024 | Acromegaly | Online First

    Quantitative ultrasound techniques and biochemical markers to assess liver steatosis and fibrosis in newly diagnosed acromegaly

    Acromegaly is a disease characterized by excessive secretion of growth hormone (GH) and insulin-like growth factor-1 (IGF-1) [ 1 ]. While increased GH in acromegaly causes a decrease in total body fat by increasing lipolysis and lipid oxidation, it …

  4. 29-04-2024 | Acromegaly | Online First

    Recurrent, polycystic myxoma in a Carney complex patient undergoing medical control of acromegaly

  5. 07-05-2024 | Acromegaly | Online First

    Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience

    Skeletal fragility is a clinically relevant and not-reversible complication of acromegaly, involving around 30–40% of patients at diagnosis and requiring a prompt and personalized schedule of prevention and management, according to well-recognized …

  6. Open Access 13-04-2024 | Acromegaly | Online First

    The effect of coping strategies on health–related quality of life in acromegaly patients

    Acromegaly is a rare and severe endocrine disorder, which is caused by unrestrained growth hormone (GH) secretion occurring after the closure of the epiphyseal plates at puberty [ 1 , 2 ]. The prevalence of acromegaly is estimated at between 2.8 …

  7. 23-03-2024 | Acromegaly | Online First

    Validity of galactin-3 in acromegaly: comparison with traditional markers

    Acromegaly is a rare condition (0.2–1.1 cases/100,000 people per year). Mostly, it is caused by pituitary adenoma with excessive production of growth hormone (GH) and subsequent insulin-like growth factor-1 (IGF-1) [ 1 ]. Cardiovascular, diabetes …

  8. 08-04-2024 | Acromegaly | Online First

    Assessment of multimodal treatment options in recurrent and persistent acromegaly: a systematic review and meta-analysis

    Acromegaly is almost always caused by a pituitary adenoma and is characterized by the effects of excessive growth hormone (GH). Previous body of evidence suggests that surgical intervention should be the first line of treatment for patients …

  9. 30-12-2023 | Acromegaly | OriginalPaper

    Acromegaly increases depressive symptoms and reduces quality of life of cohabitants

    Acromegaly is caused by excessive secretion of growth hormone (GH) mostly by pituitary adenoma. It is associated with substantial morbidity and mortality [ 1 ]. Since the diagnosis can take several years, treatment is oftenly delayed [ 2 ].

  10. Open Access 26-03-2024 | Acromegaly | Online First

    Long-term pasireotide therapy in acromegaly: extensive real-life experience of a referral center

    Acromegaly is a rare endocrine disease caused by a GH-secreting pituitary adenoma in most cases [ 1 ]. Its therapeutic approach is multidimensional and tailored to the patient [ 1 ]. Pasireotide (PAS), second-generation somatostatin receptor ligand …

  11. 23-03-2024 | Acromegaly | Online First

    Changes in multi-modality management of acromegaly in a tertiary centre over 2 decades

    Acromegaly is a chronic rare disease caused by GH-secreting pituitary adenomas[ 1 ]. Acromegaly is associated with increased morbidity, impaired quality of life and reduced life expectancy, mainly due to cardiovascular disease and cancer [ 2 , 3 ].

  12. 21-02-2024 | Acromegaly | OriginalPaper

    Glucose intolerance in acromegaly is driven by low insulin secretion; results from an intravenous glucose tolerance test

    Glucose intolerance is a frequent complication of active acromegaly [ 1 – 3 ]. It considerably impacts disease burden and choice of treatment [ 4 , 5 ], whether by itself or by interacting with other comorbidities like hypertrophic cardiomyopathy [ …6

  13. Open Access 19-03-2024 | Acromegaly | Online First

    Recurrence in acromegaly: two tertiary centers experience and review of the literature

    Acromegaly is a chronic and rare disease characterized by GH hypersecretion, most frequently caused by GH-secreting pituitary tumors arising from somatotroph cells [ 1 ]. Rare causes of acromegaly are pituitary carcinoma and ectopic production of …

  14. 18-04-2024 | Acromegaly | Online First

    Evaluation of the relation between subclinical systolic dysfunction defined by four-dimensional speckle-tracking echocardiography and growth differentiation factor-15 levels in patients with acromegaly

    Acromegaly is characterized by increased growth hormone (GH) and insulin-like growth factor-1 (IGF-1), which in the majority of cases is induced by a GH-secreting pituitary tumor. Cardiovascular disease is a highly prevalent comorbidity in …

  15. Open Access 01-12-2024 | Acromegaly | OriginalPaper

    Recurrent acromegaly: a systematic review on therapeutic approaches

    Acromegaly is a rare disease, with a prevalence ranging from 2.8 to 13.7 cases per 100,000 population [ 1 ]. It is a slowly progressive disease characterized by overproduction of growth hormone (GH) and insulin-like growth factor 1 (IGF-1) …

  16. 05-03-2024 | Acromegaly | Online First

    Immunological signatures and predictive biomarkers for first-generation somatostatin receptor ligand resistance in Acromegaly

    Acromegaly is characterized by chronic systemic manifestations resulting from hypersecretion of growth hormone (GH) and elevated levels of insulin-like growth factor-1 (IGF-1). This condition, predominantly caused by GH-secreting somatotropinomas …

  17. 10-02-2024 | Acromegaly | Online First

    The changing landscape of acromegaly – an epidemiological perspective

    Acromegaly is a rare disease and thus challenging to accurately quantify epidemiologically. In this comprehensive literature review, we compare different approaches to studying acromegaly from an epidemiological perspective and describe the …

  18. 13-03-2024 | Acromegaly | Online First

    Correction to: PRESTO 2: An International Survey to Evaluate Patients’ Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly

  19. Open Access 18-10-2023 | Acromegaly | OriginalPaper

    Establishing a valid cohort of patients with acromegaly by combining the National Patient Register with the Swedish Pituitary Register

    Acromegaly is a disease resulting from excess growth hormone (GH) derived from a pituitary tumour that causes growth of soft tissue and several associated conditions, such as sleep apnoea, arthropathy, hypertension, left ventricular dysfunction …

  20. Open Access 06-12-2023 | Acromegaly | Erratum

    Correction: consensus on criteria for acromegaly diagnosis and remission

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.